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Hyperhomocysteinaemia is Associated with the Rate of Abdominal
Aortic Aneurysm Expansion
Halazun K.J., Bofkin K.A., Asthana S., Evans C., Henderson M., Spark J.I.
Eur J Vasc Endovasc Surg 2007;33:391-4.
Objectives Previous literature has suggested an association between
AAA and the presence of elevated plasma homocysteine levels (HCY).
Homocysteine can stimulate elastolysis in the arterial media via activation of
elastase and matrix metalloproteinases. No evidence in the literature exists
correlating aneurysm expansion and HCY. The study objective is to identify
whether the rate of AAA expansion is related to HCY.
Methods 108 patients undergoing surveillance for AAAwere identified
at our vascular surgical unit. AAA size and growth rate were assessed by serial
ultrasongraphic measurements. Fasting total HCY levels were measured
using fluorescence polarisation immunoassays. Demographic details and
atherosclerotic risk factors were noted all AAA patients. A multivariate
analysis was performed for growth rate vs. HCY, hypertension and hyper-
cholesterolaemia. The correlation between AAA growth rate, AAA size and
HCY levels were calculated.
Results 60% of patients with AAA had some degree of hyperhomocys-
teinaemia (15 mol/l). Multivariate analysis showed HCY to be the only
significant factor affecting AAA growth rate. A positive correlation was demon-
strated between HCY levels and AAA growth rate using a linear regression
model (R0.28, p0.003). Median growth rate among patients with hyper-
HCY was double that of patients with normal HCY (0.5 mm/month vs.
0.25 mm/month, p0.003). A growth rate of10 mm/year was seen in 25%
of hyperHCYpatients and in only 2% of patients with normalHCY. In addition
patients with hyper HCY and larger AAAs (4 cm) had a growth rate twice as
fast as patients with hyper HCY and AAAs4 cm.
Conclusions A correlation between HCY and growth rate exists,
although this is weak due to the multifactorial aetiology of AAAs. Hyper-
HCY patients have faster expansion rates than patients with normal HCY,
with significant numbers demonstrating rapid expansion (10 mm/year)
and therefore an increased risk of rupture.
Intravascular Stapler for “Open” Aortic Surgery: Preliminary Results
Shifrin E.G., Moore W.S., Bell P.R.F., Kolvenbach R., Daniline E.I. Eur J
Vasc Endovasc Surg 2007;33:408-11.
Objectives The aim of this study was to assess the efficacy of a new
stapling device using a pig model.
Methods Straight 12 mm Gore-Tex grafts were inserted end to end
into the aorta of 12 pigs. One anastomosis was performed with the stapler
and the other using 4/0 prolene sutures and 13 mm needles. The animals
were sacrificed at one week, one and three months and all grafts underwent
histological examination. Leakage from the anastomoses was assessed in a
separate specially designed circulation model using saline as a perfusate.
Results The stapled anastomoses took 1.00.25 minutes to complete
while suturing took 8.51.5 minutes. There was no difference in the
histology between the two types of anastomosis. The leak rate was six times
greater at the sutured compared to the stapled anastomosis.
Conclusion The use of stapled anastomoses may allow a significant
shortening of aortic cross clamping time, reduce anastomotic leakage and
may be particularly useful in laparoscopic aortic repair. A randomised trial is
required to assess the efficacy of this device.
An Implantable Carotid Sinus Baroreflex Activating System: Surgical
Technique and Short-Term Outcome from a Multi-Center Feasibility
Trial for the Treatment of Resistant Hypertension
Tordoir J.H.M., Scheffers I., Schmidli J., Savolainen H., Liebeskind U.,
Hansky B., Herold U., Irwin E., Kroon A.A., de Leeuw P., Peters T.K.,
Kieval R., Cody R. Eur J Vasc Endovasc Surg 2007;33:414-21.
Objectives To assess perioperative outcomes and blood pressure (BP)
responses to an implantable carotid sinus baroreflex activating system being
investigated for the treatment of resistant hypertension.
Methods We report on the first seventeen patients enrolled in a
multicenter study. Bilateral perivascular carotid sinus electrodes (CSL) and a
pulse generator (IPG) are permanently implanted. Optimal placement of the
CSL is determined by intraoperative BP responses to test activations. Acute
BP responses were tested postoperatively and during the first four months of
follow-up.
Results Prior to implant, BP was 189.627.5/110.715.3 mmHg
despite stable therapy (5.21.8 antihypertensive drugs). The mean proce-
dure time was 20243 minutes. No perioperative strokes or deaths oc-
curred. System tests performed 1 or up to 3 days postoperatively resulted in
significant (all p0.0001) mean maximum reduction, with standard devia-
tions and 95% confidence limits for systolic BP, diastolic BP and heart rate of
2822 (17, 39) mmHg, 1611 (10, 22) mmHg and 84 (6, 11) BPM,
respectively. Repeated testing during 3 months of therapeutic electrical
activation demonstrated a durable response.
Conclusions These preliminary data suggest an acceptable safety of the
procedure with a low rate of adverse events and support further clinical devel-
opment of baroreflex activation as a new concept to treat resistant hypertension.
Aortic Arch Anomalies are Associated with Increased Risk of Neuro-
logical Events in Carotid Stent Procedures
Faggioli G.L., Ferri M., Freyrie A., Gargiulo M., Fratesi F., Rossi C.,
Manzoli L., Stella A. Eur J Vasc Endovasc Surg 2007;33:436-41.
Objective To establish the risk of carotid artery stent (CAS) complica-
tions in patients with aortic arch anomalies.
Methods In a prospective series of patients submitted to CAS, all cases
with arch anomalies were compared with cases with normal arch anatomy
(type I, II and III) in order to assess the impact of anatomic characteristics on
technical and clinical outcome. Outcome was evaluated in term of neuro-
logical complications and technical success.
Results Of 214 consecutive patients undergoing CAS, 189 (88.3%)
had normal arch anatomy and 25 (11.7%) arch anomalies. The arch abnor-
malities included common origin of brachiocephalic trunk and left common
carotid artery in 22 cases (10.2%), separate origin of right subclavian and
common carotid in 2 cases (0.9%) and left common carotid agenesis with
separate arch origin of internal and external carotid in 1 case (0.5%). The two
groups were not different in term of epidemiology and preoperative clinical
and morphological characteristics. Technical failure occurred overall in 26
cases (12%) and neurological complication in 14 cases (6.5%). All symptoms
were temporary. Technical failure was higher in the arch anomaly group;
however the difference did not reach statistical significance (89.6% vs 76.4%,
P0.1). Neurological complications occurred more frequently in the arch
anomaly group (20% vs 5.3%, P0.039). Type of arch was the only variable
independently associated with neurological complications (OR2.01,
p0.026).
Conclusion Aortic arch anomalies are not infrequent and are associ-
ated with increased risk of neurological complications. The indication for
CAS should be carefully evaluated in these cases.
Characteristics and Treatments of Patients with Peripheral Arterial
Disease Referred to UK Vascular Clinics: Results of a Prospective
Registry
Khan S., Flather M., Mister R., Delahunty N., Fowkes G., Bradbury A.,
Stansby G. Eur J Vasc Endovasc Surg 2007;33:442-50.
Background Peripheral arterial disease (PAD) is often associated with
risk factors including cigarette smoking, hypertension and hypercholester-
olaemia, and patients have a high risk of future vascular events. Good
medical management results in improved outcomes and quality of life, but
previous studies have documented sub-optimal treatment of risk factors. We
assessed the management of cardiovascular risk factors in patients with PAD
referred to specialist vascular clinics.
Methods This was a prospective, protocol driven registry carried out in
UK vascular clinics. Patients who were first-time referrals for evaluation of
PADwere eligible if they had claudication plus ankle-brachial pressure index
(ABPI) 0.9. Statistical associations between key demographic and treat-
ment variables were explored using a chi-squared test.
Results We enrolled 473 patients from 23 sites. Mean age was 68 years
(SD 10) and 66% were male. Mean estimated claudication distance was
100 m, and ABPI was 0.74. Mean systolic blood pressure (SBP) was
155 mmHg, and 42% had a SBP 160 mmHg. Forty percent were current
smokers and half had tried to give up in the prior 6 months, but there was no
evidence of a systematic method of smoking cessation. Mean total choles-
terol was 5.4 (SD1.2) mmol/l and 30% had levels6 mmol/l. Antiplatelet
therapy had been given to 70% and statins to 44%. Prior CHDwas present in
29% and these patients had significantly higher use of antiplatelet therapy,
statins and ACE-inhibitors.
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